The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells

Nature Materials

Volumn 13, Issue 4, 2014, Pages 418-426

  Maldiney, Thomas ^a   Bessière, Aurélie ^b   Seguin, Johanne ^a   Teston, Eliott ^a   Sharma, Suchinder K ^b   Viana, Bruno ^b   Bos, Adrie J J ^c   Dorenbos, Pieter ^c   Bessodes, Michel ^a   Gourier, Didier ^b   Scherman, Daniel ^a   Richard, Cyrille ^a  

^a Centre National de la Recherche Scientifique   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL APPLICATIONS; BIOMEDICAL APPLICATIONS; INTRAVENOUS INJECTIONS; OPTICAL NANO-PROBES; PERSISTENT LUMINESCENCE; SURFACE FUNCTIONALIZATION; SYSTEMIC ADMINISTRATION; TISSUE AUTOFLUORESCENCE;

CYTOLOGY; DIAGNOSIS; LIGHT; LUMINESCENCE; MEDICAL APPLICATIONS; NANOPARTICLES; OPTICAL IMAGE STORAGE; TUMORS;

CELLS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; METAL NANOPARTICLE; OXIDE;

ANIMAL; ARTICLE; CELL TRACKING; CHEMISTRY; EXPERIMENTAL NEOPLASM; FLUORESCENCE MICROSCOPY; INFRARED RADIATION; LUMINESCENCE; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; CELL TRACKING; CONTRAST MEDIA; INFRARED RAYS; LUMINESCENT MEASUREMENTS; METAL NANOPARTICLES; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; OXIDES;

EID: 84897873301     PISSN: 14761122     EISSN: 14764660     Source Type: Journal    
DOI: 10.1038/nmat3908     Document Type: Article

References (42)

1. Aitasalo, T. et al. Persistent luminescence phenomena in materials doped with rare earth ions. J. Solid State Chem. 171, 114-122 (2003).
2. Matsuzawa, T., Aoki, Y., Takeuchi, N. & Murayama, Y. A new long phosphorescent phosphor with high brightness, SrAl2O4 VEu2C,Dy3C. J. Electrochem. Soc. 143, 2670-2673 (1996).
3. le Masne de Chermont, Q. et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl Acad. Sci. USA 104, 9266-9271 (2007).
4. Maldiney, T. et al. Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice. ACS Nano 5, 854-862 (2011).
5. Maldiney, T. et al. In vivo optical imaging with rare earth doped Ca2Si5N8 persistent luminescence nanoparticles. Opt. Mat. Express 2, 11810-11815 (2012).
6. Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626-634 (2003).
7. Medintz, I. L., Uyeda, H. T., Goldman, E. R. & Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Mater. 4, 435-446 (2005).
8. Weissleder, R. & Pittet, M. J. Imaging in the era of molecular oncology. Nature 452, 580-589 (2008).
9. Richard, C. et al. Persistent luminescence nanoparticles for bioimaging. Adv. Intell. Soft Comput. 120, 37-53 (2012).
10. Wu, B. Y.,Wang, H. F., Chen, J. T. & Yan, X. P. Fluorescence resonance energy transfer inhibition assay for -fetoprotein excreted during cancer cell growth using functionalized persistent luminescence nanoparticles. J. Am. Chem. Soc. 133, 686-688 (2011).
11. Maldiney, T. et al. Synthesis and functionalization of persistent luminescence nanoparticles with small molecules and evaluation of their targeting ability. Int. J. Pharm. 423, 102-107 (2012).
12. Maldiney, T. et al. In vitro targeting of avidin-expressing glioma cells with biotinylated persistent luminescence nanoparticles. Bioconjugate Chem. 23, 472-478 (2012).
13. Jain, R. K. & Stylianopoulos, T. Delivering nanomedicine to solid tumours. Nature Rev. Clin. Oncol. 7, 653-664 (2010).
14. Danhier, F., Feron, O. & Préat, V. To exploit the tumour microenvironment: Passive and active tumour targeting of nanocarriers for anti-cancer drug delivery. J. Control. Rel. 148, 135-146 (2010).
15. Al-Jamal,W. T. et al. Tumour Targeting of Functionalized Quantum Dot-Liposome Hybrids by Intravenous Administration. Mol. Pharm. 6, 520-530 (2009).
16. Park, J. H. et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Mater. 8, 1-6 (2009).
17. Maldiney, T. et al. Controlling electron trap depth to enhance optical properties of persistent luminescence nanoparticles for in vivo imaging. J. Am. Chem. Soc. 133, 11810-11815 (2011).
18. Lecointre, A. et al. Designing a red persistent luminescence phosphor: The example of YPO4: Pr3C, Ln3C ( Ln D Nd , Er , Ho , Dy ). J. Phys. Chem. C 115, 4217-4227 (2011).
19. Maldiney, T. et al. Trap depth optimization to improve optical properties of diopside-based nanophosphors for medical imaging. Proc. SPIE 8263, 826318 (2012).
20. Bessière, A. et al. ZnGa2O4:Cr3C: a new red long-lasting phosphor with high brightness. Opt. Express 19, 10131-10137 (2011).
21. Pan, Z., Lu, Y. Y. & Liu, F. Sunlight-activated long-persistent luminescence in the near-infrared from Cr3C-doped zinc gallogermanates. Nature Mater. 11, 58-63 (2012).
22. Abrams, B. L. & Holloway, P. H. Role of the surface in luminescent processes. Chem. Rev. 104, 5783-5802 (2004).
23. Hirano, M., Imai, M. & Inagaki, M. Preparation of ZnGa2O4 spinel fine particles by the hydrothermal method. J. Am. Ceram. Soc. 83, 977-979 (2000).
24. Zhang, X. et al. Photocatalytic decomposition of benzene by porous nanocrystalline ZnGa2O4 with a high surface area. Envir. Sci. Tech. 43, 5947-5951 (2009).
25. Bessière, A. et al. Storage of visible light for long-lasting phosphorescence in chromium-doped zinc gallate. Chem. Mater. 26, 1365-1373 (2014).
26. Castano, A. P., Demidova, T. N. & Hamblin, M. R. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodynam. Therapy 1, 279-293 (2004).
27. Mikenda,W. & Preisinger, A. N-lines in the luminescence spectra of Cr3C-doped spinels: II Origins of N-lines. J. Lumin. 26, 67-83 (1981).
28. Nie,W., Michel-Calendini, F. M., Linares, C., Boulon, G. & Daul, C. New results on optical properties and term-energy calculations in Cr3C-doped ZnAl2O4. J. Lumin. 46, 177-190 (1990).
29. Yukihara, E. G. & McKeever,W. S. Optically Stimulated Luminescence: Fundamental and Applications (JohnWiley, 2011).
30. Derkosch, J & Mikenda,W. N-lines in the luminescence spectra of Cr3C-dopd spinels IV excitation spectra. J. Lumin. 28, 431-441 (1983).
31. Brito, H. F. et al. Persistent luminescence mechanisms: human imagination at work. Opt. Mater. Exp. 2, 371-381 (2012).
32. Dorenbos, P. Mechanism of persistent luminescence in Eu2C and Dy3C codoped aluminate and silicate compounds. J. Electrochem. Soc. 152, H107-H110 (2005).
33. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan,W. C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139-2147 (2012).
34. Daou, T. J., Li, L., Reiss, P., Josserand, V. & Texier, I. Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. Langmuir. 25, 3040-3044 (2009).
35. Schipper, M. L. et al. Particle size, surface coating, and pegylation influence the biodistribution of quantum dots in living mice. Small 5, 126-134 (2009).
36. Ishida, O., Maruyama, K. & Sasaki, K. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumour-bearing mice. Int. J. Pharm. 190, 49-56 (1999).
37. Poon, Z., Lee, J. B., Morton, S.W. & Hammond, P. T. Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery. Nano Lett. 11, 2096-2103 (2011).
38. Cho, E. C., Xie, J.,Wurm, P. A. & Xia, Y. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I/KI etchant. Nano Lett. 9, 180-184 (2009).
39. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan,W. C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139-2147 (2012).
40. Fidler, I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218-224 (1975).
41. Hewitt, G. et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nature Commun. 3, 1-9 (2012).
42. Kruk, P. A., Rampino, N. J. & Bohr, V. A. DNA damage and repair in telomeres: Relation to aging. Proc. Natl Acad. Sci. USA 92, 258-262 (1995).